Vectans Pharma - Transmucosal technology, targeted efficacy, improved compliance

ABOUT VECTANS PHARMA

Vectans Pharma is an international pharmaceutical company bringing a new therapeutic approach with its Lauriad® technology born of French R&D.

This innovative technology enables targeted and prolonged diffusion of APIs, thus optimizing effectiveness and compliance for the benefit of patients.

Vectans Pharma's portfolio currently comprises two products, Sitavig® and Loramyc®, both market-approved by American (FDA), European (EMA) and Japanese (PMDA) health authorities.

Through international licensing agreements, Loramyc® is commercialized in the United States, Japan, Italy and France, and Sitavig® in the United States and France.

NEWS

Exclusive licensing agreement with m8 Pharmaceuticals

m8 Pharmaceuticals and Vectans Pharma signed an exclusive licensing agreement of Loramyc® (miconazole Lauriad®) for Mexico and Brazil.

Jonathan Cohen promoted Director of Regulatory and Industrial Affairs

” It has been almost a year since Jonathan joined Vectans pharma team. Over the past few months, his professional expertise has been a major asset for our growing international development. I have no doubt that he will assume his new responsibilities with the same efficiency and wish him every…

More news

Vectans Pharma is an international pharmaceutical company bringing a new therapeutic approach with its Lauriad® technology born of French R&D.

This innovative technology enables targeted and prolonged diffusion of APIs, thus optimizing effectiveness and compliance for the benefit of patients.

Vectans Pharma's portfolio currently comprises two products, Sitavig® and Loramyc®, both market-approved by American (FDA), European (EMA) and Japanese (PMDA) health authorities.

Through international licensing agreements, Loramyc® is commercialized in the United States, Japan, Italy and France, and Sitavig® in the United States and France.

Exclusive licensing agreement with m8 Pharmaceuticals

Jonathan Cohen promoted Director of Regulatory and Industrial Affairs

ABOUT VECTANS PHARMA

SITEMAP

CONTACT